Percutaneous tracheostomy in patients on anticoagulants

Laura Pasin, Elena Frati, Luca Cabrini, Landoni Giovanni, Pasquale Nardelli, Tiziana Bove, Maria Calabro, Anna Scandroglio, Federico Pappalardo, Alberto Zangrillo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To determine if percutaneous tracheostomy is safe in critically ill patients treated with anticoagulant therapies. Settings and Design: Single-center retrospective study including all the patients who underwent percutaneous dilatational tracheostomy (PDT) placement over a 1-year period in a 14-bed, cardiothoracic and vascular Intensive Care Unit (ICU). Materials and Methods: Patients demographics and characteristics, anticoagulant and antiplatelet therapies, coagulation profile, performed technique and use of bronchoscopic guidance were retrieved. Results: Thirty-six patients (2.7% of the overall ICU population) underwent PDT over the study period. Twenty-six (72%) patients were on anticoagulation therapy, 1 patient was on antiplatelet therapy and 2 further patients received prophylactic doses of low molecular weight heparin. Only 4 patients had normal coagulation profile and were not receiving anticoagulant or antiplatelet therapies. Overall, bleeding of any severity complicated 19% of PDT. No procedure-related deaths occurred. Conclusions: PDT was proved to be safe even in critically ill-patients treated with anticoagulant therapies. Larger prospective studies are needed to confirm our findings.

Original languageEnglish
Pages (from-to)329-334
Number of pages6
JournalAnnals of Cardiac Anaesthesia
Volume18
Issue number3
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Tracheostomy
Anticoagulants
Critical Illness
Intensive Care Units
Therapeutics
Low Molecular Weight Heparin
Blood Vessels
Retrospective Studies
Demography
Prospective Studies
Hemorrhage

Keywords

  • Anticoagulants
  • Antiplatelet therapies
  • Critically ill patients
  • Intensive Care Unit
  • Percutaneous tracheostomy
  • Procedure related bleeding complications

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous tracheostomy in patients on anticoagulants. / Pasin, Laura; Frati, Elena; Cabrini, Luca; Giovanni, Landoni; Nardelli, Pasquale; Bove, Tiziana; Calabro, Maria; Scandroglio, Anna; Pappalardo, Federico; Zangrillo, Alberto.

In: Annals of Cardiac Anaesthesia, Vol. 18, No. 3, 01.07.2015, p. 329-334.

Research output: Contribution to journalArticle

Pasin, Laura ; Frati, Elena ; Cabrini, Luca ; Giovanni, Landoni ; Nardelli, Pasquale ; Bove, Tiziana ; Calabro, Maria ; Scandroglio, Anna ; Pappalardo, Federico ; Zangrillo, Alberto. / Percutaneous tracheostomy in patients on anticoagulants. In: Annals of Cardiac Anaesthesia. 2015 ; Vol. 18, No. 3. pp. 329-334.
@article{436f333eca5f47248c4beff59372ae5f,
title = "Percutaneous tracheostomy in patients on anticoagulants",
abstract = "To determine if percutaneous tracheostomy is safe in critically ill patients treated with anticoagulant therapies. Settings and Design: Single-center retrospective study including all the patients who underwent percutaneous dilatational tracheostomy (PDT) placement over a 1-year period in a 14-bed, cardiothoracic and vascular Intensive Care Unit (ICU). Materials and Methods: Patients demographics and characteristics, anticoagulant and antiplatelet therapies, coagulation profile, performed technique and use of bronchoscopic guidance were retrieved. Results: Thirty-six patients (2.7{\%} of the overall ICU population) underwent PDT over the study period. Twenty-six (72{\%}) patients were on anticoagulation therapy, 1 patient was on antiplatelet therapy and 2 further patients received prophylactic doses of low molecular weight heparin. Only 4 patients had normal coagulation profile and were not receiving anticoagulant or antiplatelet therapies. Overall, bleeding of any severity complicated 19{\%} of PDT. No procedure-related deaths occurred. Conclusions: PDT was proved to be safe even in critically ill-patients treated with anticoagulant therapies. Larger prospective studies are needed to confirm our findings.",
keywords = "Anticoagulants, Antiplatelet therapies, Critically ill patients, Intensive Care Unit, Percutaneous tracheostomy, Procedure related bleeding complications",
author = "Laura Pasin and Elena Frati and Luca Cabrini and Landoni Giovanni and Pasquale Nardelli and Tiziana Bove and Maria Calabro and Anna Scandroglio and Federico Pappalardo and Alberto Zangrillo",
year = "2015",
month = "7",
day = "1",
doi = "10.4103/0971-9784.159802",
language = "English",
volume = "18",
pages = "329--334",
journal = "Annals of Cardiac Anaesthesia",
issn = "0971-9784",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Percutaneous tracheostomy in patients on anticoagulants

AU - Pasin, Laura

AU - Frati, Elena

AU - Cabrini, Luca

AU - Giovanni, Landoni

AU - Nardelli, Pasquale

AU - Bove, Tiziana

AU - Calabro, Maria

AU - Scandroglio, Anna

AU - Pappalardo, Federico

AU - Zangrillo, Alberto

PY - 2015/7/1

Y1 - 2015/7/1

N2 - To determine if percutaneous tracheostomy is safe in critically ill patients treated with anticoagulant therapies. Settings and Design: Single-center retrospective study including all the patients who underwent percutaneous dilatational tracheostomy (PDT) placement over a 1-year period in a 14-bed, cardiothoracic and vascular Intensive Care Unit (ICU). Materials and Methods: Patients demographics and characteristics, anticoagulant and antiplatelet therapies, coagulation profile, performed technique and use of bronchoscopic guidance were retrieved. Results: Thirty-six patients (2.7% of the overall ICU population) underwent PDT over the study period. Twenty-six (72%) patients were on anticoagulation therapy, 1 patient was on antiplatelet therapy and 2 further patients received prophylactic doses of low molecular weight heparin. Only 4 patients had normal coagulation profile and were not receiving anticoagulant or antiplatelet therapies. Overall, bleeding of any severity complicated 19% of PDT. No procedure-related deaths occurred. Conclusions: PDT was proved to be safe even in critically ill-patients treated with anticoagulant therapies. Larger prospective studies are needed to confirm our findings.

AB - To determine if percutaneous tracheostomy is safe in critically ill patients treated with anticoagulant therapies. Settings and Design: Single-center retrospective study including all the patients who underwent percutaneous dilatational tracheostomy (PDT) placement over a 1-year period in a 14-bed, cardiothoracic and vascular Intensive Care Unit (ICU). Materials and Methods: Patients demographics and characteristics, anticoagulant and antiplatelet therapies, coagulation profile, performed technique and use of bronchoscopic guidance were retrieved. Results: Thirty-six patients (2.7% of the overall ICU population) underwent PDT over the study period. Twenty-six (72%) patients were on anticoagulation therapy, 1 patient was on antiplatelet therapy and 2 further patients received prophylactic doses of low molecular weight heparin. Only 4 patients had normal coagulation profile and were not receiving anticoagulant or antiplatelet therapies. Overall, bleeding of any severity complicated 19% of PDT. No procedure-related deaths occurred. Conclusions: PDT was proved to be safe even in critically ill-patients treated with anticoagulant therapies. Larger prospective studies are needed to confirm our findings.

KW - Anticoagulants

KW - Antiplatelet therapies

KW - Critically ill patients

KW - Intensive Care Unit

KW - Percutaneous tracheostomy

KW - Procedure related bleeding complications

UR - http://www.scopus.com/inward/record.url?scp=84936777070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936777070&partnerID=8YFLogxK

U2 - 10.4103/0971-9784.159802

DO - 10.4103/0971-9784.159802

M3 - Article

C2 - 26139737

AN - SCOPUS:84936777070

VL - 18

SP - 329

EP - 334

JO - Annals of Cardiac Anaesthesia

JF - Annals of Cardiac Anaesthesia

SN - 0971-9784

IS - 3

ER -